Teleflex Incorporated (NYSE:TFX) Receives $146.00 Consensus PT from Analysts

Shares of Teleflex Incorporated (NYSE:TFX) have earned a consensus rating of “Hold” from the ten research firms that are covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, five have given a hold rating and four have issued a buy rating on the company. The average 1 year price target among brokerages that have covered the stock in the last year is $146.00.

Several equities analysts have recently weighed in on the stock. Wall Street Zen raised shares of Teleflex from a “sell” rating to a “hold” rating in a research note on Saturday, June 27th. Truist Financial reiterated a “hold” rating and issued a $143.00 price objective (up from $135.00) on shares of Teleflex in a report on Monday, May 11th. Piper Sandler raised shares of Teleflex from a “neutral” rating to an “overweight” rating and raised their target price for the stock from $140.00 to $160.00 in a research note on Monday, June 8th. Royal Bank Of Canada raised shares of Teleflex from a “sector perform” rating to an “outperform” rating and raised their target price for the stock from $135.00 to $155.00 in a research note on Friday, May 8th. Finally, Mizuho set a $140.00 target price on Teleflex in a report on Friday, May 8th.

Teleflex Stock Performance

Shares of NYSE:TFX opened at $134.09 on Friday. The company has a debt-to-equity ratio of 0.82, a current ratio of 2.55 and a quick ratio of 2.03. Teleflex has a 1 year low of $100.18 and a 1 year high of $139.67. The firm has a market capitalization of $5.94 billion, a PE ratio of -5.88, a P/E/G ratio of 1.00 and a beta of 0.82. The business’s 50 day moving average price is $129.95 and its 200-day moving average price is $119.79.

Teleflex (NYSE:TFX) last announced its quarterly earnings data on Thursday, May 7th. The medical technology company reported $1.39 earnings per share for the quarter, beating analysts’ consensus estimates of $1.21 by $0.18. Teleflex had a positive return on equity of 13.29% and a negative net margin of 35.88%.The company had revenue of $548.30 million for the quarter, compared to analyst estimates of $536.91 million. During the same quarter last year, the firm posted $1.44 EPS. The firm’s revenue for the quarter was up 32.3% on a year-over-year basis. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. As a group, equities research analysts expect that Teleflex will post 6.7 earnings per share for the current fiscal year.

Teleflex Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 30th. Shareholders of record on Monday, May 25th were paid a dividend of $0.34 per share. The ex-dividend date of this dividend was Friday, May 22nd. This represents a $1.36 dividend on an annualized basis and a yield of 1.0%. Teleflex’s payout ratio is -5.96%.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the stock. Janus Henderson Group PLC boosted its position in shares of Teleflex by 1.1% during the 1st quarter. Janus Henderson Group PLC now owns 4,291,311 shares of the medical technology company’s stock valued at $513,281,000 after acquiring an additional 45,199 shares during the last quarter. AQR Capital Management LLC raised its stake in Teleflex by 478.1% during the third quarter. AQR Capital Management LLC now owns 2,366,131 shares of the medical technology company’s stock worth $287,603,000 after purchasing an additional 1,956,811 shares during the period. State Street Corp raised its stake in Teleflex by 1.5% during the fourth quarter. State Street Corp now owns 1,478,776 shares of the medical technology company’s stock worth $180,470,000 after purchasing an additional 22,111 shares during the period. Dimensional Fund Advisors LP boosted its holdings in Teleflex by 0.4% in the 4th quarter. Dimensional Fund Advisors LP now owns 1,250,665 shares of the medical technology company’s stock valued at $152,630,000 after purchasing an additional 5,051 shares during the last quarter. Finally, Geode Capital Management LLC boosted its holdings in Teleflex by 10.6% in the 4th quarter. Geode Capital Management LLC now owns 985,684 shares of the medical technology company’s stock valued at $120,312,000 after purchasing an additional 94,679 shares during the last quarter. Hedge funds and other institutional investors own 95.62% of the company’s stock.

About Teleflex

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.